GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,419 | -5,440 | -58,013 | -39,991 | -34,538 |
| Accounts payable and accrued liabilities | -1,729 | -838 | 7,077 | 537 | -611 |
| Other Working Capital | -1,761 | -1,100 | 8,660 | 1,505 | -309 |
| Other Operating Activity | 3,908 | 2,163 | 26,670 | 26,048 | 27,486 |
| Operating Cash Flow | $-8,001 | $-5,215 | $-15,606 | $-11,901 | $-7,972 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 4,614 | 3,533 | N/A | -26,031 | N/A |
| Purchase Of Investment | N/A | N/A | -23,040 | N/A | N/A |
| Investing Cash Flow | $4,614 | $3,533 | $-23,040 | $-26,031 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 1,205 | 1,205 | 1,205 |
| Common Stock Issued | N/A | N/A | 41,112 | 41,112 | 40,975 |
| Other Financing Activity | -223 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $-223 | $N/A | $42,317 | $42,317 | $42,180 |
| Beginning Cash Position | 8,968 | 8,968 | 5,297 | 5,297 | 5,297 |
| End Cash Position | 5,358 | 7,286 | 8,968 | 9,682 | 39,505 |
| Net Cash Flow | $-3,610 | $-1,682 | $3,671 | $4,385 | $34,208 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,001 | -5,215 | -15,606 | -11,901 | -7,972 |
| Free Cash Flow | -8,001 | -5,215 | -15,606 | -11,901 | -7,972 |